We tested the effect of Hsp90 inhibitor treatment on cell migration in the metastatic pheochromocytoma cell line MTT and found that 17-AAG reduced serum-stimulated migration (Fig. 2A and B), with an IC50 of 144 nM. The gene discussed is HSP90AB1; the disease is hereditary pheochromocytoma-paraganglioma.